Trastuzumab Recruiting Phase 2 Trials for Malignant Neoplasm of Stomach / Malignant Neoplasm of Cardio-esophageal Junction of Stomach / Epidermal Growth Factor Receptor (EGFR) Protein Overexpression Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT02725424Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy